Liraglutide Modulates Appetite and Body Weight Through Glucagon-Like Peptide 1 Receptor–Expressing Glutamatergic Neurons

Glucagon-like peptide 1 receptor (GLP-1R) agonists are U.S. Food and Drug Administration–approved weight loss drugs. Despite their widespread use, the sites of action through which GLP-1R agonists (GLP1RAs) affect appetite and body weight are still not fully understood. We determined whether GLP-1Rs...

Descripción completa

Detalles Bibliográficos
Autores principales: Adams, Jessica M., Pei, Hongjuan, Sandoval, Darleen A., Seeley, Randy J., Chang, Rui B., Liberles, Stephen D., Olson, David P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2018
Materias:
Obesity Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054439/
https://www.ncbi.nlm.nih.gov/pubmed/29776968
http://dx.doi.org/10.2337/db17-1385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054439/
https://www.ncbi.nlm.nih.gov/pubmed/29776968
http://dx.doi.org/10.2337/db17-1385

Ejemplares similares